Integer (ITGR) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Integer Revenue Highlights

Latest Revenue (Y)

$1.85B

Latest Revenue (Q)

$467.69M

Main Segment (Y)

Cardio And Vascular

Main Geography (Y)

UNITED STATES

Integer Revenue by Period

Integer Revenue by Year

Date	Revenue	Change
2025-12-31	$1.85B	7.98%
2024-12-31	$1.72B	10.35%
2023-12-31	$1.56B	16.85%
2022-12-31	$1.33B	9.02%
2021-12-31	$1.22B	13.75%
2020-12-31	$1.07B	-14.68%
2019-12-31	$1.26B	3.55%
2018-12-31	$1.22B	6.95%
2017-12-31	$1.14B	5.63%
2016-12-31	$1.08B	34.37%
2015-12-31	$800.41M	16.38%
2014-12-31	$687.79M	3.59%
2013-12-31	$663.95M	2.75%
2012-12-31	$646.18M	13.60%
2011-12-31	$568.82M	6.64%
2010-12-31	$533.42M	2.22%
2009-12-31	$521.82M	-4.54%
2008-12-31	$546.64M	71.50%
2007-12-31	$318.75M	17.56%
2006-12-31	$271.14M	12.46%
2005-12-31	$241.10M	20.48%
2004-12-31	$200.12M	-7.51%
2003-12-31	$216.37M	29.33%
2002-12-31	$167.30M	23.40%
2001-12-31	$135.57M	38.64%
2000-12-31	$97.79M	23.42%
1999-12-31	$79.23M	-

Integer generated $1.85B in revenue during NA 2025, up 7.98% compared to the previous quarter, and up 172.68% compared to the same period a year ago.

Integer Revenue by Quarter

Date	Revenue	Change
2025-09-26	$467.69M	-1.85%
2025-06-27	$476.49M	8.94%
2025-03-28	$437.39M	-2.69%
2024-12-31	$449.50M	4.19%
2024-09-27	$431.42M	-1.18%
2024-06-28	$436.57M	5.25%
2024-03-29	$414.80M	0.40%
2023-12-31	$413.15M	2.09%
2023-09-29	$404.69M	1.16%
2023-06-30	$400.04M	5.61%
2023-03-31	$378.79M	1.71%
2022-12-31	$372.42M	8.68%
2022-09-30	$342.68M	-2.11%
2022-07-01	$350.08M	12.60%
2022-04-01	$310.91M	-0.67%
2021-12-31	$313.01M	2.44%
2021-10-01	$305.57M	-2.07%
2021-07-02	$312.02M	7.42%
2021-04-02	$290.47M	8.00%
2020-12-31	$268.96M	13.99%
2020-10-02	$235.94M	-1.74%
2020-07-03	$240.12M	-26.89%
2020-04-03	$328.43M	0.86%
2019-12-31	$325.64M	7.26%
2019-09-27	$303.59M	-3.38%
2019-06-28	$314.19M	-0.15%
2019-03-29	$314.68M	3.84%
2018-12-31	$303.03M	-0.67%
2018-09-28	$305.09M	-2.98%
2018-06-29	$314.46M	-17.62%
2018-03-30	$381.75M	-2.24%
2017-12-29	$390.48M	7.48%
2017-09-29	$363.31M	0.16%
2017-06-30	$362.72M	5.01%
2017-03-31	$345.41M	-3.94%
2016-12-30	$359.59M	3.76%
2016-09-30	$346.57M	-0.52%
2016-07-01	$348.38M	4.86%
2016-04-01	$332.24M	4.62%
2016-01-01	$317.57M	116.57%
2015-10-02	$146.64M	-16.15%
2015-07-03	$174.89M	8.41%
2015-04-03	$161.32M	-4.95%
2014-12-31	$169.73M	-1.15%
2014-09-30	$171.70M	-0.22%
2014-06-30	$172.08M	-1.26%
2014-03-31	$174.28M	-1.32%
2014-01-03	$176.62M	5.30%
2013-09-27	$167.73M	-2.10%
2013-06-28	$171.33M	15.56%
2013-03-29	$148.26M	-6.86%
2012-12-28	$159.19M	-1.34%
2012-09-28	$161.34M	-3.13%
2012-06-29	$166.55M	4.68%
2012-03-30	$159.10M	12.25%
2011-12-30	$141.75M	7.61%
2011-09-30	$131.72M	-10.10%
2011-07-01	$146.52M	-1.55%
2011-04-01	$148.83M	11.81%
2010-12-31	$133.11M	4.41%
2010-10-01	$127.49M	-9.45%
2010-07-02	$140.79M	6.64%
2010-04-02	$132.03M	4.94%
2010-01-01	$125.81M	3.57%
2009-10-02	$121.47M	-9.84%
2009-07-03	$134.72M	-3.64%
2009-04-03	$139.82M	-4.63%
2009-01-02	$146.60M	7.60%
2008-09-26	$136.24M	-3.82%
2008-06-27	$141.65M	15.96%
2008-03-28	$122.15M	44.71%
2007-12-28	$84.42M	-

Integer generated $467.69M in revenue during Q3 2025, up -1.85% compared to the previous quarter, and up 107.13% compared to the same period a year ago.

Integer Revenue Breakdown

Integer Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Cardiac Rhythm Management & Neuromodulation	$668.80M	$660.61M	-	-	-
Cardio And Vascular	$1.11B	$949.58M	-	-	-
Other Markets	$77.75M	$106.41M	-	-	-
Medical Segment	-	-	$1.55B	$1.33B	$1.18B
Non-Medical Segment	-	-	$43.33M	$46.55M	$38.45M

Integer's latest annual revenue breakdown by segment (product or service), as of Dec 25: Cardio And Vascular (59.72%), Cardiac Rhythm Management & Neuromodulation (36.08%), and Other Markets (4.19%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jul 22	Apr 22	Oct 21	Jul 21	Apr 21	Oct 20	Jul 20
Cardio And Vascular	$284.21M	$277.15M	$286.86M	$258.87M	$708.57M	$241.01M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Markets	$20.55M	$21.39M	$17.64M	$18.18M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cardiac Rhythm Management & Neuromodulation	$167.30M	$169.16M	$172.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Advanced Surgical, Orthopedics, and Portable Medical	-	-	-	-	-	$25.31M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Medical Segment	-	-	-	-	-	-	$427.38M	$407.21M	$404.06M	$395.90M	$389.11M	$364.27M	$330.91M	$339.83M	$302.03M	$296.12M	$301.63M	$282.96M	$227.68M	$231.38M
Non-Medical Segment	-	-	-	-	-	-	$8.82M	$7.59M	$9.09M	$8.79M	$10.93M	$14.52M	$11.77M	$10.25M	$8.88M	$9.45M	$10.40M	$7.50M	$8.26M	$8.73M

Integer's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Cardio And Vascular (60.21%), Cardiac Rhythm Management & Neuromodulation (35.44%), and Other Markets (4.35%).

Integer Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
UNITED STATES	$979.81M	$938.67M	$897.43M	$762.13M	$671.50M
Rest Of World	$469.88M	$516.17M	$501.25M	$423.74M	$372.44M
PUERTO RICO	$131.26M	$137.06M	$108.42M	$114.08M	$110.16M
IRELAND	$99.16M	-	-	-	-

Integer's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (58.32%), Rest Of World (27.97%), PUERTO RICO (7.81%), and IRELAND (5.90%).

Integer Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CON	Concentra Group Parent	$2.16B	$572.80M
ITGR	Integer	$1.85B	$467.69M
ADUS	Addus HomeCare	$1.42B	$362.30M
LIVN	LivaNova	$1.39B	$357.80M
HAE	Haemonetics	$1.36B	$338.97M
INSP	Inspire Medical Systems	$911.98M	$224.50M
UFPT	UFP	$602.80M	$154.56M
AORT	Artivion	$441.33M	$113.39M
PRCT	PROCEPT BioRobotics	$308.05M	$83.33M
RXRX	Recursion Pharmaceuticals	$74.68M	$5.17M

ITGR Revenue FAQ

What is Integer’s yearly revenue?

Integer's yearly revenue for 2025 was $1.85B, representing an increase of 7.98% compared to 2024. The company's yearly revenue for 2024 was $1.72B, representing an increase of 10.35% compared to 2023. ITGR's yearly revenue for 2023 was $1.56B, representing an increase of 16.85% compared to 2022.

What is Integer’s quarterly revenue?

Integer's quarterly revenue for Q3 2025 was $467.69M, a -1.85% decrease from the previous quarter (Q2 2025), and a 8.41% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $476.49M, a 8.94% increase from the previous quarter (Q1 2025), and a 9.14% increase year-over-year (Q2 2024). ITGR's quarterly revenue for Q1 2025 was $437.39M, a -2.69% decrease from the previous quarter (Q4 2024), and a 5.45% increase year-over-year (Q1 2024).

What is Integer’s revenue growth rate?

Integer's revenue growth rate for the last 3 years (2023-2025) was 19.15%, and for the last 5 years (2021-2025) was 51.80%.

What are Integer’s revenue streams?

Integer's revenue streams in c 25 are Cardiac Rhythm Management & Neuromodulation, Cardio And Vascular, and Other Markets. Cardiac Rhythm Management & Neuromodulation generated $668.8M in revenue, accounting 36.08% of the company's total revenue, up 1.24% year-over-year. Cardio And Vascular generated $1.11B in revenue, accounting 59.72% of the company's total revenue, up 16.59% year-over-year. Other Markets generated $77.75M in revenue, accounting 4.19% of the company's total revenue, down -26.93% year-over-year.

What is Integer’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Integer was Cardio And Vascular. This segment made a revenue of $1.11B, representing 59.72% of the company's total revenue.